Growth Metrics

Alkermes (ALKS) Accumulated Expenses (2016 - 2025)

Alkermes (ALKS) has disclosed Accumulated Expenses for 14 consecutive years, with $82.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 16.19% to $82.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $82.4 million, a 16.19% increase, with the full-year FY2025 number at $82.4 million, up 16.19% from a year prior.
  • Accumulated Expenses was $82.4 million for Q4 2025 at Alkermes, down from $252.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $282.0 million in Q3 2024 to a low of $43.1 million in Q1 2025.
  • A 5-year average of $125.7 million and a median of $78.2 million in 2021 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: soared 404.98% in 2024, then plummeted 82.11% in 2025.
  • Alkermes' Accumulated Expenses stood at $77.3 million in 2021, then grew by 2.37% to $79.1 million in 2022, then increased by 5.09% to $83.1 million in 2023, then decreased by 14.62% to $71.0 million in 2024, then grew by 16.19% to $82.4 million in 2025.
  • Per Business Quant, the three most recent readings for ALKS's Accumulated Expenses are $82.4 million (Q4 2025), $252.7 million (Q3 2025), and $56.5 million (Q2 2025).